Newswise — Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (NIH) in Bethesda, MD, will speak on HIV/AIDS : Much Accomplished, Much to Do at the Uniformed Services University of the Health Sciences (USU) May 16 as part of the university's annual Research Week.
Dr. Fauci has been instrumental in developing strategies for therapy and immune reconstitution in leading the world's efforts in fundamental research on HIV/AIDS and in developing strategies for therapy and immune reconstitution. He continues his research in pursuit of identifying the nature of the immunopathogenic mechanisms of HIV infection and the scope of the body's immune responses to the AIDS retrovirus.
He has been one of the most-cited scientists in all disciplines throughout the world who published articles in scientific journals and was the world's 10th most-cited HIV/AIDS researcher in the period 1996-2006. He recently received the 2007 George M. Kober Medal of the Association of American Physicians (AAP) for his outstanding contributions to academic medicine. The Kober Medal is named after George M. Kober, M.D., a pioneer in public health reform in the late 19th century and the early 20th century. It recognizes physicians acknowledged as leaders in internal medicine and is the highest honor of the Association of American Physicians.
USU researchers are at the forefront of HIV/AIDS research by currently studying bone loss in HIV patients and analyzing gene therapy trials using CD4 zeta gene modified T cell infusions. Other Research Week lectures on HIV/AIDS include: Pre-clinical and Clinical HIV Research in the Department of Defense IDCRP HIV Research, COL Scott Wegner, MC, USAF; Progress in HIV Preventive Vaccine Development, COL Matt Dolan, MC, USAF and Translational Clinical Research: MRSA in the HIV-Infected Military Clinic Population, Nancy Crum-Cianflonel, Naval Medical Center San Diego.
The university's nationally ranked military and civilian faculty conduct cutting edge research in the biomedical sciences and in areas specific to the DoD health care mission such as combat casualty, infectious diseases, and radiation biology. The university is committed to technology transfer to ensure that the results of research are made widely available and currently holds more than 289 patents or pending patents.
RSS